Swedish Orphan Biovitrum AB's market cap is currently ―. The company's EPS TTM is kr10.301; its P/E ratio is ―; Swedish Orphan Biovitrum AB is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is kr3.40. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 5.99B	$ 4.00B	$ 3.88B	$ 4.92B	$ 4.90B
Gross Profit	$ 4.68B	$ 3.07B	$ 2.86B	$ 3.41B	$ 3.88B
EBIT	$ 1.88B	$ 699.00M	$ 323.00M	$ 776.00M	$ 1.51B
EBITDA	$ 2.47B	$ 1.28B	$ 888.00M	$ 1.46B	$ 2.04B
Net Income Common Stockholders	$ 1.39B	$ 451.00M	$ 258.00M	$ 543.00M	$ 1.24B
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.36B	$ 288.00M	$ 360.00M	$ 1.06B	$ 1.04B
Total Assets	$ 52.50B	$ 50.93B	$ 48.43B	$ 48.81B	$ 48.66B
Total Debt	$ 9.10B	$ 10.18B	$ 9.85B	$ 9.77B	$ 10.91B
Net Debt	$ 7.74B	$ 9.89B	$ 9.49B	$ 8.71B	$ 9.86B
Total Liabilities	$ 25.97B	$ 25.87B	$ 24.10B	$ 25.05B	$ 25.46B
Stockholders Equity	$ 26.52B	$ 25.07B	$ 24.33B	$ 23.76B	$ 23.20B
Cash Flow	-
Free Cash Flow	$ 1.83B	$ 56.00M	$ -191.00M	$ 1.49B	$ 1.88B
Operating Cash Flow	$ 1.90B	$ 780.00M	$ 343.00M	$ 1.64B	$ 2.12B
Investing Cash Flow	$ -63.00M	$ -724.00M	$ -533.00M	$ -157.00M	$ -245.00M
Financing Cash Flow	$ -776.00M	$ -174.00M	$ -550.00M	$ -1.49B	$ -1.05B

Currency in USD

Swedish Orphan Biovitrum AB Earnings and Revenue History

Income Statement >

Swedish Orphan Biovitrum AB Debt to Assets

Balance Sheet >

Swedish Orphan Biovitrum AB Cash Flow

Cash Flow >

Swedish Orphan Biovitrum AB Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing